OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis

Pharmacogenomics. 2013 May;14(7):813-24. doi: 10.2217/pgs.13.57.

Abstract

The OPRM1 gene encodes the µ-opioid receptor, which is the primary site of action of most opioids. Several studies and three meta-analyses have examined a possible link between the exonic OPRM1 A118G (rs1799971) polymorphism and opioid dependence; however, results have been inconclusive. Therefore, a systematic review and meta-analysis have been carried out to examine whether this polymorphism is associated with opioid dependence. Thirteen studies (n = 9385), comprising 4601 opioid dependents and 4784 controls, which evaluated association of the OPRM1 rs1799971 polymorphism with susceptibility to opioids, were included in this study. Our meta-analysis showed significant association between this polymorphism and susceptibility to opioid dependence in overall studies under a codominant model, as well as susceptibility to opioid dependence or heroin dependence in Asians under an autosomal dominant model. The nonsynonymous OPRM1 rs1799971 might be a risk factor for addiction to opioids or heroin in an Asian population.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Analgesics, Opioid / adverse effects
  • Asian People / genetics
  • Genetic Predisposition to Disease
  • Heroin Dependence / genetics*
  • Humans
  • Polymorphism, Genetic
  • Receptors, Opioid, mu / genetics*
  • Risk Factors

Substances

  • Analgesics, Opioid
  • OPRM1 protein, human
  • Receptors, Opioid, mu